Article in Blood advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
15 authors.
Mary FigueroaDepartment of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-7926-4532
Huaxian MaDepartment of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
Mansour AlfayezDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.
Daniel Enrique Morales-MantillaDivision of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX.
Fei WangDepartment of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
Yue LuDepartment of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, TX.
Marcos R EstecioCenter of Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-6874-7413
Katherine Y KingDivision of Infectious Diseases, Department of Pediatrics, Baylor College of Medicine, Houston, TX.ORCID 0000-0002-5093-6005
Eugenie KleinermanDepartment of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX.
Seyed Javad MoghaddamDepartment of Pulmonary Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-5350-307X
Naval DaverDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-7103-373X
Michael AndreeffDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-1144-1958
Marina KonoplevaDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-9347-2212
Courtney DiNardoDepartment of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-9003-0390
Joya ChandraDepartment of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-2077-9715
Funding
Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
Translational Research Support CoreP30ES030285 · NIEHS · BAYLOR COLLEGE OF MEDICINE · PI Cheryl L. Walker · 2019 to 2026
$14.7M
Impact of Infection and Inflammation on Primitive HematopoiesisR35HL155672 · NHLBI · BAYLOR COLLEGE OF MEDICINE · PI Katherine Yudeh King · 2021 to 2026
$5.1M
Single Cell Spatial Analysis in TissueR50CA243707 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BURKS, JARED KYLE · 2020 to 2024
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cigarette smoke exposure accelerates AML progression in FLT3-ITD models. · full record | OpenQuestion